small molecule

IWILFIN

EFLORNITHINE HYDROCHLORIDE

Loss of exclusivityFebruary 2036latest FDA-listed patent expiry

CompanyUSWM, LLC →See this company's full patent-cliff portfolio

Drug detail

Brand name	IWILFIN
Active ingredient	EFLORNITHINE HYDROCHLORIDE
Strength	EQ 192MG BASE
Dosage form	TABLET
Route	ORAL
Modality	Small molecule
FDA approval	December 2023
Marketing status	RX

Listed patents

Patent	Expires	Type
12582625	February 2036	use U-4444

Regulatory exclusivity

Code	Expires
ODE-462	December 2030
NP	December 2026

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Drug detail

Listed patents

Regulatory exclusivity

More from USWM, LLC